Fangzhou Jianke (06086.HK) successfully held its 2026 "Double 11" Partner Conference in Guangzhou, themed "AI Innovation for Efficiency, Data Services for Empowerment," bringing together industry experts, partners, and frontline practitioners to explore the industrial value of data services and innovative pathways for personalized full-lifecycle health services.
At the conference, Fangzhou Jianke announced a strategic partnership with Cutia Group. Leveraging the wave of the AI era and diverse patient health needs, the two parties will focus on product pipeline collaboration and "AI + digital intelligent marketing" as strategic entry points, fully connecting innovative medical achievements with digital health services to accelerate the implementation of medical innovations for public benefit.
Fangzhou Jianke Executive Director and CEO Wang Haijiao and Cutia Group Executive Director and CEO Zhang Lele jointly signed the strategic cooperation agreement (provided by the company).
AI Innovation Gathers Momentum for Win-Win Industrial Ecosystem
In recent years, domestic demand for long-term health management has continued to rise, while pain points in traditional healthcare models—such as insufficient follow-up, low patient compliance, and long pathways for innovative drug reach—have become increasingly prominent. With the deepening of the Healthy China strategy, building a full chain integrating AI technology, supply chain, and data services to create a new health ecosystem has become an inevitable direction for high-quality industry development.
As a leading domestic "AI + chronic disease services" platform, Fangzhou Jianke continues to refine its innovative model. At this partner conference, it showcased its achievements in the first half of 2026—with the Xingshi large model as its core technological foundation, the company is accelerating the large-scale implementation of digital intelligent tools: AI health assistants and AI medication assistants enhance user experience, while tools like AI pre-consultation and AI academic assistants reduce burdens on the physician side. Additionally, the company deeply integrates AI capabilities into key health management scenarios such as health monitoring, follow-up management, and health education, truly achieving precise alignment between cutting-edge technological innovation and public health needs.
Fangzhou Jianke Executive Director and CEO Wang Haijiao stated that the company has built a complete AI digital intelligent matrix integrating "full-lifecycle health management, full-chain supply chain, data services, and digital intelligent marketing." Next, it will open core capabilities such as "AI + health services" and digital intelligent marketing to industry partners, hoping to collaborate with more partners to explore the industrial value of data services, jointly explore innovative models for personalized full-lifecycle health management, and provide new inspiration for industry development.
Joining Forces for New Horizons: Fangzhou Jianke and Cutia Group Forge Strategic Partnership
At the meeting, Fangzhou Jianke also announced a formal deep strategic partnership with Cutia Group. Cutia Group深耕 skin and hair disease and other pan-dermatology tracks, having established a full industry chain loop from drug research and development, manufacturing, to commercial implementation. Through dual drivers of self-developed innovation and overseas introduction, it continuously iterates and expands its product pipeline, making it a benchmark enterprise with strong innovative capabilities in the domestic pan-dermatology sector.
Fangzhou Jianke and Cutia Group have long enjoyed a deep cooperative friendship. In this strategic partnership, both parties share a common goal—to reconstruct a newer, more user-health-need-aligned "AI + full-cycle health services" ecosystem. Wang Haijiao remarked: "Today we have reached a deep strategic partnership with Cutia Group, serving a vast domestic user base and meeting their more diverse health needs. Leveraging Fangzhou Jianke's mature 'AI + chronic disease services' capabilities and Cutia Group's rich medical innovations, we plan to create a series of personalized health service packages, forming a closed loop of products, one-on-one follow-ups, online assessments, and health guidance, paving a health management path better suited to users."
Cutia Group Executive Director and CEO Zhang Lele stated that significant unmet clinical needs remain in the skin health field, and he looks forward to leveraging Fangzhou Jianke's mature AI technology and digital intelligent service capabilities to shorten the distance between innovative products and users, enabling more patients to conveniently access standardized, professional long-term health management services.
This partner conference gathered wisdom from multiple industry parties, not only showcasing Fangzhou Jianke's exploration achievements in the "AI + chronic disease services" field this year but also outlining a blueprint for the upgrading of the big health industry under the AI wave. Next, the company will continue to anchor in the "AI + chronic disease services" track, extensively linking upstream and downstream ecosystem partners in the industry chain, and gathering continuous industrial momentum for the high-quality development of Healthy China.
Comments